Bluejay Diagnostics, Inc. (NASDAQ:BJDX) IPO
IPO
Priced at US$10.00 a unit on Nov 9, 2021.
- Price
- US$10.00 a unit
- Units offered
- 2,160,000 units
- Offering size
- US$21.6 million
- Underwriters' option
- Up to 324,000 more units
- Listing
- BJDX on the Nasdaq Capital Market
- Underwriters
- Dawson James Securities, Inc., I-Bankers Direct, LLC · In the order on the cover
- Units delivered
- On or about Nov 15, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 22, 2021 |
| Filed publicly | Oct 4, 2021 |
| Amended twice | Newest Nov 3, 2021 |
| Shares registered with an exchange | Nov 5, 2021 |
| Declared effective by the SEC | Nov 9, 2021 |
| Final prospectus, with the price | Nov 12, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Nov 12, 2021 |
| EFFECT · Notice that a registration is effective | Nov 9, 2021 |
| S-1MEF · Registration of more shares for the same offering | Nov 9, 2021 |
| CORRESP · Letter to the SEC | Nov 5, 2021 |
| CERT · Exchange's certificate of listing | Nov 5, 2021 |
| CORRESP · Letter to the SEC | Nov 5, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 5, 2021 |
| S-1/A · Registration statement, amended | Nov 3, 2021 |
| FWP · Free writing prospectus | Oct 27, 2021 |
| CORRESP · Letter to the SEC | Oct 25, 2021 |
| S-1/A · Registration statement, amended | Oct 25, 2021 |
| UPLOAD · Letter from the SEC | Oct 15, 2021 |
| CORRESP · Letter to the SEC | Oct 4, 2021 |
| S-1 · Registration statement | Oct 4, 2021 |
| UPLOAD · Letter from the SEC | Sep 24, 2021 |
| DRSLTR · Letter to the SEC with a draft | Sep 8, 2021 |
| DRS/A · Draft registration statement, amended | Sep 8, 2021 |
| UPLOAD · Letter from the SEC | Aug 20, 2021 |
| DRS · Draft registration statement | Jul 22, 2021 |
From the cover of the final prospectus (424B4) filed Nov 12, 2021